GSA Capital Partners’s Clearside Biomedical CLSD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $427K | Buy |
533,524
+331,935
| +165% | +$266K | 0.03% | 1028 |
|
|
2025
Q1 | $185K | Buy |
+201,589
| New | +$185K | 0.02% | 1409 |
|
|
2022
Q3 | – | Sell |
-98,097
| Closed | -$144K | – | 1560 |
|
|
2022
Q2 | $144K | Buy |
98,097
+19,823
| +25% | +$29.1K | 0.02% | 1157 |
|
|
2022
Q1 | $179K | Buy |
+78,274
| New | +$179K | 0.02% | 1199 |
|
|
2021
Q1 | – | Sell |
-59,832
| Closed | -$164K | – | 1149 |
|
|
2020
Q4 | $164K | Buy |
59,832
+6,635
| +12% | +$18.2K | 0.03% | 1033 |
|
|
2020
Q3 | $82K | Sell |
53,197
-895
| -2% | -$1.38K | 0.01% | 1152 |
|
|
2020
Q2 | $102K | Buy |
+54,092
| New | +$102K | 0.06% | 482 |
|
|
2019
Q3 | – | Sell |
-127,018
| Closed | -$123K | – | 1430 |
|
|
2019
Q2 | $123K | Sell |
127,018
-104,858
| -45% | -$102K | 0.01% | 1320 |
|
|
2019
Q1 | $320K | Buy |
231,876
+111,866
| +93% | +$154K | 0.03% | 952 |
|
|
2018
Q4 | $128K | Buy |
120,010
+20,000
| +20% | +$21.3K | 0.01% | 1192 |
|
|
2018
Q3 | $615K | Buy |
100,010
+50,100
| +100% | +$308K | 0.03% | 971 |
|
|
2018
Q2 | $534K | Buy |
+49,910
| New | +$534K | 0.03% | 1125 |
|
|
2018
Q1 | – | Sell |
-12,600
| Closed | -$88K | – | 1622 |
|
|
2017
Q4 | $88K | Sell |
12,600
-51,600
| -80% | -$360K | 0.01% | 1486 |
|
|
2017
Q3 | $561K | Buy |
+64,200
| New | +$561K | 0.04% | 894 |
|